Director at Murphy USA (NYSE: MUSA) granted 421 restricted stock units

Rhea-AI Filing Summary

DEMING CLAIBORNE P reported acquisition or exercise transactions in this Form 4 filing.

Murphy USA Inc. director Claiborne P. Deming reported receiving an award of 421 restricted stock units on February 12, 2026. The grant was made at a price of $0 per unit under the company’s 2023 Omnibus Incentive Plan.

After this award, the director directly holds 1,219.02 derivative securities linked to Murphy USA common stock. Settlement of certain restricted stock units and related dividend equivalent units has been deferred until the director’s termination of service from the board, consistent with their deferral election.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEMING CLAIBORNE P

(Last) (First) (Middle)

200 PEACH STREET

(Street)

EL DORADO AR 71730

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Murphy USA Inc. [ MUSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	(2)	02/12/2026		A		421		(2)(3)	(2)(3)	Common Stock	421	$0	1,219.02(4)	D

Explanation of Responses:

1. Award granted under the 2023 Omnibus Incentive Plan.

2. These Securities generally do not carry a Conversion Price, Exercisable Date, or Expiration Date.

3. The reporting person has elected to defer settlement of certain restricted stock units and accrued dividend equivalent units thereon to the reporting person's termination of service from the Board, in accordance with their deferral election form.

4. Includes dividend equivalent units accrued with respect to the underlying RSUs.

	/s/ Gregory L. Smith, attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Murphy USA (MUSA) report for Claiborne P. Deming?

Murphy USA reported that director Claiborne P. Deming received 421 restricted stock units on February 12, 2026. The award was granted at a price of $0 per unit under the 2023 Omnibus Incentive Plan as part of equity-based director compensation.

How many Murphy USA (MUSA) restricted stock units does the director hold after this Form 4?

Following the reported grant, the director beneficially owns 1,219.02 derivative securities tied to Murphy USA common stock. This total includes the newly awarded 421 restricted stock units and related accrued dividend equivalent units, all held as direct ownership according to the filing details.

What is the nature of the equity award reported for Murphy USA (MUSA) director Deming?

The filing shows a grant of restricted stock units as a derivative security. These units were issued under Murphy USA’s 2023 Omnibus Incentive Plan, with no cash exercise price, reflecting standard stock-based compensation rather than an open-market purchase of common shares.

When will the reported Murphy USA (MUSA) restricted stock units be settled?

The director elected to defer settlement of certain restricted stock units and related dividend equivalent units until their termination of service from the Murphy USA board. This deferral follows the director’s previously filed deferral election form referenced in the transaction footnotes.

Do the Murphy USA (MUSA) restricted stock units have an expiration date or conversion price?

According to the footnotes, these restricted stock units generally do not have a conversion price, exercisable date, or expiration date. They represent a right to receive Murphy USA common stock in the future, subject to the plan and the director’s deferral election terms.

Are dividend equivalents included in the Murphy USA (MUSA) director’s reported holdings?

Yes. The filing notes that the total derivative securities include dividend equivalent units accrued on the underlying restricted stock units. These additional units mirror dividends on Murphy USA common stock and increase the director’s reported beneficial ownership figure of 1,219.02 units.